Position in ARGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$277,031,194
+$28,538,073 QoQ
Shares Held
298,599
-12.3% QoQ
Ownership
0.480%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#15
of 505 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 75%
Shared 0%
None 25%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SANDS CAPITAL MANAGEMENT, LLC holds $382,489,101 across 2 Biotechnology names. ARGX ranks #1 (72.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
This page
|
298,599 | $277,031,194 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
3,158,368 | $105,457,907 |
All Filings in ARGX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $277,031,194 | 298,599 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $248,493,121 | 340,285 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $300,109,826 | 356,870 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,261,935 | 16,625 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||